Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-046787
Filing Date
2013-10-02
Accepted
2013-10-02 17:45:01
Documents
1
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7161
  Complete submission text file 0001209191-13-046787.txt   8411
Mailing Address
Business Address
GLENN SCOTT L (Reporting) CIK: 0001284095 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36075 | Film No.: 131131473

Mailing Address 12555 HIGH BLUFF DRIVE SUITE 385 San Diego CA 92130
Business Address 12555 HIGH BLUFF DRIVE SUITE 385 San Diego CA 92130 (760) 487-1255
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations